Thursday - February 05, 2026

Category Archives: Pharmaceuticals & Biotech

Global AI in Healthcare Market Projected to Reach $110.61 Billion by 2030

Artificial Intelligence (AI) in Healthcare Market Enterprise healthcare leaders face unprecedented pressure to optimize diagnostics, treatment, and operations—AI solutions now offer a decisive competitive advantage The global artificial intelligence in healthcare market is experiencing explosive growth, valued at $21.66 billion … Continue reading →

Dermatomyositis Treatment Pipeline Shows Strong Momentum as 10+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Dermatomyositis Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dermatomyositis pipeline landscape. It covers the Dermatomyositis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dermatomyositis pipeline therapeutics … Continue reading →

Human Papillomavirus-positive Oropharyngeal Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Human Papillomavirus-positive Oropharyngeal Cancer pipeline landscape. It covers the Human Papillomavirus-positive Oropharyngeal Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Acromegaly Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Acromegaly Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in the Acromegaly pipeline landscape. It covers the Acromegaly pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acromegaly pipeline … Continue reading →

Cannabinoid Agonist Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Cannabinoid Agonist Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Cannabinoid Agonist pipeline landscape. It covers the Cannabinoid Agonist pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Renal Cancer Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Renal Cancer Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Chronic Lower Back Pain Therapeutics Market Size in the 7MM was approximately USD 6,071 million in 2023, estimates DelveInsight

Chronic Lower Back Pain Market CLBP companies are Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG, Inc., Kolon Life Science, Eliem Therapeutics, Allodynic Therapeutics, Sollis Therapeutics, Medtronic … Continue reading →

Epilepsy Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading →